ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 275656 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 275656; 2) Community: the network communities that were significantly associated with the response to NSC 275656; 3) Molecule: the relationships between components within communities and NSC 275656; 4) MDR: the compounds that were significantly associated with the NSC 275656.

NSC Compound Enrichment Correlation
NSC 720326 2-(5,6,7-Trimethoxyindol-2-carbonyl)amino-4H-pyrazolo[1,5-a] indole 0.0152777849043084 0.094124841
NSC 745813 Null 0.0152777849043084 0.1743283
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0152777849043084 0.21719444
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0164116791870034 0.52340238
NSC 303812 Aphidicoline glycinate 0.0164116791870036 0.81267095
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0164116791870036 0.35393037
NSC 45236 Null 0.0164116791870036 0.32604793
NSC 603071 Aminocamptothecin 0.0164116791870036 0.76468563
NSC 606497 Camptothecin Derivative 0.0164116791870036 0.82031581
NSC 615291 Bizelesin 0.0164116791870036 0.81325295
Total:73  Current:27    [First] [Prev] [Next] [Last]